Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Truc T Tran

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Scientific Reports|March 30, 2020
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population StructureRafael Rios, Jinnethe Reyes, Lina P Carvajal, et al.
Open Forum Infectious Diseases|June 5, 2024
Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than <i>Enterococcus faecalis</i> or <i>E. faecium</i> in Patients With CancerDierdre B Axell-House, Patrycja A Ashley, Stephanie L Egge, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Mutations in <i>cdsA</i> and <i>pgsA</i> Correlate with Daptomycin Resistance in <i>Streptococcus mitis</i> and <i>S. oralis</i>Truc T Tran, Nagendra N Mishra, Ravin Seepersaud, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in <i>Pseudomonas aeruginosa</i> of clinical originStephanie L Egge, Samie A Rizvi, Shelby R Simar, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in <i>Pseudomonas aeruginosa</i> of clinical originStephanie L Egge, Samie A Rizvi, Shelby R Simar, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2022
Multisite Detection of Tn<i>1549</i>-Mediated <i>vanB</i> Vancomycin Resistance in Multidrug-Resistant Enterococcus faecalis ST6 in Texas and FloridaShelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2016
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?Bhavarth S Shukla, Samuel Shelburne, Katherine Reyes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosaJose M Munita, Samuel L Aitken, William R Miller, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2024
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolatesKevin J Westbrook, Gayatri Shankar Chilambi, Madison E Stellfox, et al.
Emerging Infectious Diseases|September 25, 2015
Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, BrazilDiana Panesso, Paul J Planet, Lorena Diaz, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Scientific Reports|March 30, 2020
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population StructureRafael Rios, Jinnethe Reyes, Lina P Carvajal, et al.
Open Forum Infectious Diseases|June 5, 2024
Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than <i>Enterococcus faecalis</i> or <i>E. faecium</i> in Patients With CancerDierdre B Axell-House, Patrycja A Ashley, Stephanie L Egge, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2018
Mutations in <i>cdsA</i> and <i>pgsA</i> Correlate with Daptomycin Resistance in <i>Streptococcus mitis</i> and <i>S. oralis</i>Truc T Tran, Nagendra N Mishra, Ravin Seepersaud, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in <i>Pseudomonas aeruginosa</i> of clinical originStephanie L Egge, Samie A Rizvi, Shelby R Simar, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in <i>Pseudomonas aeruginosa</i> of clinical originStephanie L Egge, Samie A Rizvi, Shelby R Simar, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2022
Multisite Detection of Tn<i>1549</i>-Mediated <i>vanB</i> Vancomycin Resistance in Multidrug-Resistant Enterococcus faecalis ST6 in Texas and FloridaShelby R Simar, Truc T Tran, Kirsten B Rydell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2016
Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?Bhavarth S Shukla, Samuel Shelburne, Katherine Reyes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosaJose M Munita, Samuel L Aitken, William R Miller, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2024
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolatesKevin J Westbrook, Gayatri Shankar Chilambi, Madison E Stellfox, et al.
Emerging Infectious Diseases|September 25, 2015
Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, BrazilDiana Panesso, Paul J Planet, Lorena Diaz, et al.
Pageof 9